Citation
Atkinson V, Long GV, Menzies AM, McArthur G, Carlino MS, Millward M, et al. Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists. Asia Pac J Clin Oncol 2016 Dec;12 Suppl 7:5-12 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/27905182.
Critical appraisals
Compare quality appraisals for each clinical question
Cited by
Social links